Topical Wound Spray HP802-247

Known as: Allogeneic Keratinocyte/Fibroblast Topical Spray HP802-247, HP802-247, HP802247 
A cell-based combination product consisting of a fibrinogen solution and a cell preparation containing allogeneic non-proliferating, living human… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2010-2016
0120102016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
OBJECTIVE The objective of this study was to characterize factors associated with closure of venous leg ulcers (VLUs) in a pooled… (More)
Is this relevant?
Review
2016
Review
2016
In 2012 we reported promising results from a phase 2 clinical trial of HP802-247, a novel spray-applied investigational treatment… (More)
Is this relevant?
2013
2013
Patients who participated in a Phase 2 trial of HP802-247 for venous leg ulcers were invited to participate in this 24-week… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2013
2013
HP802-247 is a living cell suspension of cultured allogeneic growth-arrested human male keratinocytes and fibroblasts (1:9 ratio… (More)
Is this relevant?
2013
2013
OBJECTIVES To determine the effectiveness of HP802-247 compared with bacitracin ointment in healing wounds resulting from Mohs… (More)
Is this relevant?
2010
2010
BACKGROUND HP802-247 is a new-generation, allogeneic tissue engineering product consisting of growth-arrested, human… (More)
Is this relevant?